These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 932502)

  • 61. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pyrogenic and haematological effects of the interferon-inducing 22K factor (interleukin 1 beta) from human leukocytes.
    van Damme J; Opdenakker G; de Ley M; Heremans H; Billiau A
    Clin Exp Immunol; 1986 Nov; 66(2):303-11. PubMed ID: 3493097
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Typhoid-paratyphoid (TAB) vaccine as interferon inducer in mice.
    Kandefer-Szerszeń M
    Acta Microbiol Pol A; 1973; 5(3):156-62. PubMed ID: 4358715
    [No Abstract]   [Full Text] [Related]  

  • 64. [Production of interferon in patients with influenza].
    Solov'ev VD; Bektemirov TA; Nekliudova LI
    Vopr Virusol; 1968; 13(2):146-51. PubMed ID: 5707261
    [No Abstract]   [Full Text] [Related]  

  • 65. The role of sialic acid in determining the survival of circulating interferon.
    Bocci V; Pacini A; Pessina GP; Bargigli V; Russi M
    Experientia; 1977 Feb; 33(2):164-6. PubMed ID: 844537
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of interferon in protection of rabbits against rinderpest virus.
    Fujisaki Y; Ishii S; Watanabe M
    Natl Inst Anim Health Q (Tokyo); 1968; 8(3):122-31. PubMed ID: 5712545
    [No Abstract]   [Full Text] [Related]  

  • 67. Human leukocyte interferon: production, purification, stability, and animal experiments.
    Cantell K; Hirvonen S; Mogensen KE; Pyhälä L
    In Vitro Monogr; 1974; (3):35-8. PubMed ID: 4620359
    [No Abstract]   [Full Text] [Related]  

  • 68. Human leukocyte interferon: production, purification to homogeneity, and initial characterization.
    Rubinstein M; Rubinstein S; Familletti PC; Miller RS; Waldman AA; Pestka S
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):640-4. PubMed ID: 284389
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interferon crosses blood-cerebrospinal fluid barrier in monkeys.
    Habif DV; Lipton R; Cantell K
    Proc Soc Exp Biol Med; 1975 May; 149(1):287-9. PubMed ID: 1144440
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circulating interferon in rabbits after simultaneous intramuscular administration of human alpha and gamma interferons.
    Cantell K; Fiers W; Hirvonen S; Pyhälä L
    J Interferon Res; 1984; 4(2):291-3. PubMed ID: 6431022
    [No Abstract]   [Full Text] [Related]  

  • 71. Quantitative determination of human leukocyte interferon by microfluorometric immunoassay with FITC-labeled anti-interferon immunoglobulin.
    Skurkovich SV; Olshansky AJ; Samoilova RS; Eremkina EI
    J Immunol Methods; 1978; 19(2-3):119-24. PubMed ID: 342608
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Renal metabolism of homologous serum interferon.
    Bocci V; Di Francesco P; Pacini A; Pessina GP; Rossi GB; Sorrentino V
    Antiviral Res; 1983 Mar; 3(1):53-8. PubMed ID: 6191655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Routes of Antigen Injection in Rabbits.
    Greenfield EA
    Cold Spring Harb Protoc; 2018 Sep; 2018(9):. PubMed ID: 30181227
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interim report on studies on "toxic" effects of human leucocyte-derived interferon-alpha (HuIFN-alpha).
    Scott GM; Wallace J; Tyrrell DA; Cantell K; Secher DS; Stewart WE
    J Interferon Res; 1982; 2(1):127-30. PubMed ID: 6180101
    [No Abstract]   [Full Text] [Related]  

  • 75. Heterogeneity of rabbit serum interferons.
    Ke YH; Ho M; Merigan TC
    Nature; 1966 Jul; 211(5048):541-2. PubMed ID: 5338578
    [No Abstract]   [Full Text] [Related]  

  • 76. A general, fast, and sensitive micromethod for DNA determination application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells.
    Fiszer-Szafarz B; Szafarz D; Guevara de Murillo A
    Anal Biochem; 1981 Jan; 110(1):165-70. PubMed ID: 7011093
    [No Abstract]   [Full Text] [Related]  

  • 77. The clearance and degradation of oligodeoxynucleotides following intravenous injection into rabbits.
    Goodchild J; Kim B; Zamecnik PC
    Antisense Res Dev; 1991; 1(2):153-60. PubMed ID: 1841657
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetic studies with human and rat interferons-gamma in different species.
    Cantell K; Schellekens H; Pyhälä L; Hirvonen S; Van der Meide PH; De Reus A
    J Interferon Res; 1986 Dec; 6(6):671-5. PubMed ID: 3106524
    [No Abstract]   [Full Text] [Related]  

  • 79. Role of liver in the inactivation of interferon.
    Bocci V; Russi-Sorce M; Cirri G; Rita G
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):62-5. PubMed ID: 4176732
    [No Abstract]   [Full Text] [Related]  

  • 80. Role of the carbohydrate moiety in determining the survival of interferon in the circulation.
    Bose S; Hickman J
    J Biol Chem; 1977 Dec; 252(23):8336-7. PubMed ID: 924995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.